Healthcare -
Biotechnology - NASDAQ - US
$ 0.8696
-0.046 %
$ 47.4 M
Market Cap
10.87
P/E
SPRO - PRE-TAX INCOME
Pre-tax Income SPRO - Spero Therapeutics, Inc.
25.4 M
LAST VALUE
51.10%
2 YEAR CAGR
21.15%
5 YEAR CAGR
0.00%
10 YEAR CAGR